Asterias Biotherapeutics
Data Breaches, Cyber Attacks and Security Report  ᛫ 
Last updated January 18, 2020

About Asterias Biotherapeutics

Company Overview

BioTime, Inc. is a clinical-stage biotechnology company headquartered in Alameda, California. BioTime stock is traded on the New York Stock Exchange American Exchange under ticker symbol BTX. BioTime focuses primarily on aesthetics, ophthalmology and cell and drug delivery. The company is in clinical trials for dry age-related macular degeneration (dry AMD) and facial lipoatrophy in HIV patients.





Fremont, CA, United States.

Data Breaches and Security News

Asterias Biotherapeutics Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Asterias Biotherapeutics is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Asterias Biotherapeutics

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Asterias Biotherapeutics's security performance with other companies